LNPEP and psoriasis: Furthermore, angiotensin IV, via angiotensin IV receptors, reportedly activates the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway and increases expression of pro-inflammatory genes [26], similar to the pathogenesis of psoriasis, which involves NF-κB and IL-23 signaling [27].